These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Molecular mechanisms of cancer cachexia]. Lelbach A, Muzes G, Feheŕ J. Orv Hetil; 2004 Nov 14; 145(46):2329-34. PubMed ID: 16106904 [Abstract] [Full Text] [Related]
7. Cytokines and cancer anorexia cachexia syndrome. Bennani-Baiti N, Davis MP. Am J Hosp Palliat Care; 2008 Nov 14; 25(5):407-11. PubMed ID: 18403577 [Abstract] [Full Text] [Related]
8. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia. Cahlin C, Körner A, Axelsson H, Wang W, Lundholm K, Svanberg E. Cancer Res; 2000 Oct 01; 60(19):5488-93. PubMed ID: 11034092 [Abstract] [Full Text] [Related]
10. Catabolic mediators as targets for cancer cachexia. Argilés JM, Moore-Carrasco R, Busquets S, López-Soriano FJ. Drug Discov Today; 2003 Sep 15; 8(18):838-44. PubMed ID: 12963320 [Abstract] [Full Text] [Related]
11. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Argilés JM, Busquets S, Felipe A, López-Soriano FJ. Int J Biochem Cell Biol; 2005 May 15; 37(5):1084-104. PubMed ID: 15743680 [Abstract] [Full Text] [Related]
12. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Mantovani G, Macciò A, Lai P, Massa E, Ghiani M, Santona MC. Semin Oncol; 1998 Apr 15; 25(2 Suppl 6):45-52. PubMed ID: 9625383 [Abstract] [Full Text] [Related]
13. Waste management - cytokines, growth factors and cachexia. Saini A, Al-Shanti N, Stewart CE. Cytokine Growth Factor Rev; 2006 Dec 15; 17(6):475-86. PubMed ID: 17118696 [Abstract] [Full Text] [Related]
14. Targets in clinical oncology: the metabolic environment of the patient. Argilés JM, Busquets S, Moore-Carrasco R, Figueras M, Almendro V, López-Soriano FJ. Front Biosci; 2007 May 01; 12():3024-51. PubMed ID: 17485280 [Abstract] [Full Text] [Related]
15. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients. Fortunati N, Manti R, Birocco N, Pugliese M, Brignardello E, Ciuffreda L, Catalano MG, Aragno M, Boccuzzi G. Oncol Rep; 2007 Dec 01; 18(6):1521-7. PubMed ID: 17982639 [Abstract] [Full Text] [Related]
16. Pathogenesis of cancer cachexia. Tisdale MJ. J Support Oncol; 2003 Dec 01; 1(3):159-68. PubMed ID: 15334872 [Abstract] [Full Text] [Related]
17. Cytokines as mediators and targets for cancer cachexia. Argilés JM, Busquets S, López-Soriano FJ. Cancer Treat Res; 2006 Dec 01; 130():199-217. PubMed ID: 16610709 [Abstract] [Full Text] [Related]
18. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours. Negri DR, Mezzanzanica D, Sacco S, Gadina M, Benigni F, Cajola L, Finocchiaro G, Ghezzi P, Canevari S. Cytokine; 2001 Jul 07; 15(1):27-38. PubMed ID: 11509006 [Abstract] [Full Text] [Related]
19. [Recent development in research and management of cancer anorexia-cachexia syndrome]. Inui A. Gan To Kagaku Ryoho; 2005 Jun 07; 32(6):743-9. PubMed ID: 15984510 [Abstract] [Full Text] [Related]
20. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia. Catalano MG, Fortunati N, Arena K, Costelli P, Aragno M, Danni O, Boccuzzi G. Int J Oncol; 2003 Aug 07; 23(2):429-36. PubMed ID: 12851692 [Abstract] [Full Text] [Related] Page: [Next] [New Search]